IMARC Group has recently released a new research study titled “United States Artificial Intelligence in Healthcare Market Report by Offering (Hardware, Software, Services), Technology (Machine Learning, Context-Aware Computing, Natural Language Processing, and Others), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), End User (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, and Others), and Region 2025-2033” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Overview

The United States Artificial Intelligence in Healthcare market size was USD 6.0 Billion in 2024. According to IMARC Group, the market is expected to reach USD 139.5 Billion by 2033, exhibiting a strong CAGR of 41.78% during the forecast period from 2025 to 2033. This growth is driven by the increasing demand for AI tools that empower healthcare professionals with evidence-based insights and comprehensive data analysis for more informed decision-making. The market leverages AI techniques such as machine learning and natural language processing to support early disease detection and personalized treatment.

Study Assumption Years

• Base Year: 2024

• Historical Year/Period: 2019-2024

• Forecast Year/Period: 2025-2033

United States Artificial Intelligence in Healthcare Market Key Takeaways

• Current Market Size: USD 6.0 Billion in 2024

• CAGR: 41.78%

• Forecast Period: 2025-2033

• The market utilizes AI techniques including machine learning, context-aware computing, natural language processing, and others.

• Key applications include robot-assisted surgery, virtual nursing assistants, administrative workflow assistance, fraud detection, dosage error reduction, clinical trial participant identifiers, and preliminary diagnosis.

• End users comprise healthcare providers, pharmaceutical and biotechnology companies, patients, and others.

• The market is segmented by offerings: hardware, software, and services.

• Geographic segmentation includes Northeast, Midwest, South, and West regions within the United States.

• The competitive landscape features comprehensive analysis including market structure and player evaluations.

Sample Request Link: https://www.imarcgroup.com/united-states-artificial-intelligence-in-healthcare-market/requestsample

Market Growth Factors

The growth of the United States AI in Healthcare market is primarily driven by the rising demand for tools that offer healthcare professionals evidence-based insights and recommendations derived from comprehensive data analysis. This demand enhances informed and efficient decision-making processes, proving indispensable in the modern healthcare environment. The large and growing availability of extensive patient data such as electronic health records, medical images, and genomic data supports this trend by providing a rich dataset for AI techniques to analyze for patterns and predictions.

Artificial intelligence in healthcare incorporates multiple advanced techniques like machine learning, natural language processing, computer vision, and expert systems to support clinical decision-making, enhance diagnostic accuracy, and facilitate personalized treatment planning. These multifaceted applications aim to improve early disease detection, optimize treatment efficacy, and enable predictive analytics and precision medicine, thereby boosting operational efficiency across healthcare providers.

Furthermore, the United States' commitment to integrating innovative AI technologies into healthcare for improving patient care quality and operational efficiency is expected to propel market expansion during the forecast period. The escalating adoption of AI-driven solutions is also stimulated by the need to enhance treatment outcomes, reduce errors such as dosage inaccuracies, and assist with administrative and workflow tasks, contributing to the overall growth trajectory of this sector.

United States Artificial Intelligence In Healthcare Market Segmentation

Offering Insights:

• Hardware: Includes physical AI devices and infrastructure used in healthcare settings to support AI applications.

• Software: Encompasses AI-driven programs and platforms facilitating data analysis, diagnostics, and treatment planning.

• Services: Covers comprehensive consulting, implementation, and support services to deploy and manage AI healthcare solutions.

Technology Insights:

• Machine Learning: AI systems that learn from large datasets to make clinical predictions or decisions.

• Context-Aware Computing: Technology that adapts AI responses based on environmental or contextual data.

• Natural Language Processing: Techniques enabling AI to interpret and utilize human language within healthcare data.

• Others: Additional AI technologies applied within the healthcare domain.

Application Insights:

• Robot-Assisted Surgery: AI-driven robotic systems that assist surgeons during procedures, enhancing precision and outcomes.

• Virtual Nursing Assistant: AI applications providing remote care support and patient monitoring.

• Administrative Workflow Assistance: Solutions to automate and optimize administrative healthcare processes.

• Fraud Detection: AI tools aimed at identifying fraudulent activities within healthcare billing and treatment claims.

• Dosage Error Reduction: AI interventions to minimize medication and dosage errors.

• Clinical Trial Participant Identifier: AI systems used to identify suitable participants for clinical research.

• Preliminary Diagnosis: Early-stage diagnostic tools powered by AI to assist healthcare professionals.

• Others: Additional applications within the healthcare AI spectrum.

End User Insights:

• Healthcare Providers: Hospitals, clinics, and other medical institutions utilizing AI technologies.

• Pharmaceutical and Biotechnology Companies: Entities involved in drug discovery and development employing AI.

• Patients: Individuals benefiting from AI-enabled healthcare services.

• Others: Other stakeholders in the healthcare ecosystem using AI.

Regional Insights:

• Northeast

• Midwest

• South

• West

The market segments cover hardware, software, and services offerings with various AI technologies and applications tailored for different end users and geographic regions.

Regional Insights

The report segments the United States into Northeast, Midwest, South, and West regions. 

The segmentation highlights the market’s comprehensive regional coverage, ensuring tailored AI healthcare solutions across diverse geographic zones within the country.

Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=20514&flag=C

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302